"Super testing" conducted early in this year's Arlington Park meet resulted in 26 positives for prednisone but found no evidence of other prohibited substances, according to the Illinois Racing Board.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
More than 700 samples have been reviewed through the National Thoroughbred Racing Association's "super testing" program, with another 1,100 on the way before an Aug. 1 deadline. But in the absence of national equine medication rules, the "calling of positives" will depend upon the jurisdiction.
In a letter to the National Thoroughbred Racing Association, a group of chemists and veterinarians who form the Testing Integrity Program has warned that "super testing," as it is called, could create a public relations nightmare for the racing industry should the betting public believe use of illegal medications is rampant.
Most Popular Stories
- Terranovas Seek Derby Success With El Kabeir
- Sherman: Ascot Could Be Rough on 'Chrome'
- U.S. Alleges Conspiracy at Penn National
- Luck of the Kitten Starts '15 in Transylvania
- Is Mubtaahij a Major Derby Contender?
- El Kabeir Fires Bullet Work at Belmont
- California Chrome Headed to Royal Ascot
- Keeneland Plans Wide Live Broadcast Coverage
- ROAP Seeks Regulation of 'Program Trainers'
- Untapable Heads Asmussen Workers at Oaklawn